Researchers from the University of South Florida, the University of Missouri, A.T. Still University, Indiana University, and the Children’s Hospital Colorado asked that exact question in their recent study. Focused specifically on patients with mild cognitive impairment, they concluded the following:

“Preliminary findings show that daily elderberry juice consumption for 6 months in patients with MCI is feasible and well tolerated and may provide some benefit to visuospatial cognitive flexibility. Patterns of preliminary blood-based inflammatory markers suggest that elderberry juice may lead to the reduction in low-grade inflammation compared with a placebo–control. These promising preliminary findings provide support for larger, more definitive prospective studies with longer follow-ups to better understand mechanisms of action and the clinical utility of elderberries for potentially mitigating cognitive decline.”

Read the full article here:

Feasibility and Preliminary Efficacy of American Elderberry Juice for Improving Cognition and Inflammation in Patients with Mild Cognitive Impairment